Universal-Beteiligungs- und Servicegesellschaft
DYN icon

Universal-Beteiligungs- und Servicegesellschaft’s Dyne Therapeutics DYN Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Sell
11,801
-2,598
-18% -$44.8K ﹤0.01% 1973
2025
Q4 		$282K Buy
+14,399
New +$273K ﹤0.01% 1887

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's DYN Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Dyne Therapeutics (DYN) stake by 18% in Q1 2026, selling an estimated $44.8K and leaving 11,801 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in DYN in Q4 2025 and has held it in 2 quarters since. The position peaked at $282K in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 11,801 shares of Dyne Therapeutics worth $214K as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 2,598 Dyne Therapeutics shares in Q1 2026, an estimated $44.8K.
  • Dyne Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #1973 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Dyne Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Dyne Therapeutics position peaked at $282K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.